No Competing Products. Neither Pfenex nor its Affiliates currently owns, in-licenses or is in the process of in-licensing a Competing Product in any stage of development or Commercialization or currently has any ongoing program to develop or acquire such a Competing Product. Pfenex has not out-licensed or otherwise granted rights to any Third Party under any Pfenex Technology with respect to Product or a Competing Product, in each case in the Territory.
No Competing Products. DISTRIBUTOR shall not distribute or resell products that compete with the Products in the Territory, whether directly or indirectly.
No Competing Products. Neither Alvogen nor its Affiliates currently owns or is in the process of in-licensing a Competing Product in any stage of development or Commercialization or currently has any ongoing program to develop or acquire such a Competing Product.
No Competing Products. Licensee may not produce any stand alone product, specifically no grid or table creation library for direct sales that would compete with Licensor’s products.
No Competing Products. Except for Company Products, Distributor will not represent or distribute during the term of this Agreement any * * *-device or greater in-parallel (* * *) probe card products, or any probing technology that competes with Company Products. Distributor warrants that Exhibit D lists all of the manufacturers and distributors, and their respective products, that Distributor represents or distributes as of the date of full execution of this Agreement.
No Competing Products. 41 15.3 Independent R&D................................................. 42
No Competing Products. Neither Hospira nor its Affiliates currently owns or in-licenses a Competing Product in any stage of development or commercialization or have any currently ongoing program to develop or acquire such a Competing Product.
No Competing Products. To the extent permitted by applicable law, Warner and GenVec each agree that it shall not sell or commercialize in the Territory, on its own or through a Third Party, during the Term of the Agreement, any product that (i) has the same therapeutic mechanism of action as a Collaboration Product, and (ii) such Party knew or reasonably should have known would compete with or be a substitute for such Collaboration Product, unless the Executive Committee, which will operate in good faith, determines that such product has significant medical or commercial advantages over such Collaboration Product. GenVec agrees not to authorize and to use reasonable efforts not to encourage or induce any Third Party to use, sell or commercialize any Gene Therapy product which would reasonably be expected to have an adverse material impact on a Collaboration Product for use for an indication to which Warner retains rights under this Agreement, or to conduct such activities itself.
No Competing Products. MG shall not market or sell any products that compete with the WRT Products for use in the Territory, provided that WRT is in compliance with the terms of this Agreement.
No Competing Products. During the first three years of the Agreement, Distributor will not sell any products, for use in the Territory, except the Software or software provided by Sagent which is later made available under this Agreement. After three years, Distributor shall be free to sell and service products of any manufacturer including those products that could compete with Sagent products provided that Distributor is otherwise in compliance with the terms of this Agreement.
